And then we decide whether we're going to offer the patient the DBS.

I totally agree with you, Michel.

And actually, in our sense, it's pretty much aligned as you just described the process.

More and more, it's always very individualized decisions, as you pointed it out.

We have our thresholds, our guidelines to some extent, but also, as you mentioned, the 30% Lividopa threshold.

response to the Vodopa, it's not necessarily a cutoff that always has to be respected.

It always depends.

But the miracle is DBS itself.